Clinical Trials Browser

Phase 2 × Uveal Melanoma × Protein Subunit Vaccines × Clear all

NCT00334776 2014-05-21

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma